Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak
After more than 28,000 Ebola virus disease cases and at least 11,000 deaths in West Africa during the 2014–2016 epidemic, the world remains without a licensed vaccine or therapeutic broadly available and demonstrated to alleviate suffering. This deficiency has been felt acutely in the two,...
Main Authors: | David Brett-Major, James Lawler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/10/8/439 |
Similar Items
-
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
by: Ian Crozier, et al.
Published: (2022-07-01) -
Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
by: Daniel N. Wolfe, et al.
Published: (2020-11-01) -
Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop
by: Rona Hirschberg, et al.
Published: (2014-07-01) -
Clinical Management of Filovirus-Infected Patients
by: Danielle V. Clark, et al.
Published: (2012-09-01) -
Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia
by: Jeffrey R. Kugelman, et al.
Published: (2015-07-01)